SCHEMBL23841122

SCHEMBL23841122

Cc1ccc(-c2cc(-c3ccc(F)cc3)[nH]c(=N)c2C#N)o1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 12/20 0.58
▸ ALDH1A1 P00352 12/20 0.58
▸ KDM4E B2RXH2 11/20 0.58
▸ HPGD P15428 9/20 0.58
▸ GAA P10253 9/20 0.58
▸ GLA P06280 8/20 0.58
▸ PKM P14618 7/20 0.58
▸ ATM Q13315 3/20 0.58
▸ KMT2A Q03164 11/20 0.52
▸ MEN1 O00255 10/20 0.52
▸ ALOX12 P18054 4/20 0.52
▸ HTT P42858 3/20 0.52
▸ MAPK1 P28482 1/20 0.46
▸ RECQL P46063 3/20 0.42
▸ BLM P54132 3/20 0.42
▸ POLB P06746 3/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ APEX1 P27695 1/20 0.42
▸ NPSR1 Q6W5P4 2/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29331867 0.88 MAPT (0.46) MAPTALDH1A1KDM4EHPGDGAA
SCHEMBL23841110 0.85 KDM4E (0.59) MAPTALDH1A1KDM4EHPGDGAA
SCHEMBL23841138 0.78 ATM (0.57) MAPTALDH1A1KDM4EHPGDGAA
SCHEMBL23841123 0.77 MAPK14 (0.47) MAPTALDH1A1KDM4EHPGDGAA
SCHEMBL29331877 0.76 KDM4E (0.46) MAPTALDH1A1KDM4EHPGDGAA
SCHEMBL29335418 0.75 IL4 (0.54) MAPTALDH1A1KDM4EGAAATM
SCHEMBL31695313 0.75 IL4 (0.54) MAPTALDH1A1KDM4EGAAATM
SCHEMBL29331948 0.75 SQOR (0.53) MAPTALDH1A1KDM4EHPGDGAA
SCHEMBL29335410 0.75 KDM4E (0.49) MAPTALDH1A1KDM4EHPGDGAA
SCHEMBL31695294 0.74 KDR (0.50) MAPTALDH1A1KDM4EHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-10-09 — — US disclosed
US-12043621-B2 Small molecule inhibitors of Interleukin-4 TRUSTEES OF BOSTON UNIVERSITY (US) 2024-07-23 — — US disclosed
US-20210317114-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 TRUSTEES OF BOSTON UNIVERSITY (US) 2021-10-14 — — US disclosed
WO-2021188871-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 TRUSTEES OF BOSTON UNIVERSITY (US) 2021-09-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12043621-B2 Small molecule inhibitors of Interleukin-4 IL4, IL2, IL4I1 MAPT 1310/4885ALDH1A1 3144/4885KDM4E 586/4885
US-20210317114-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 IL4, IL2, IL4I1 MAPT 1310/4885ALDH1A1 3144/4885KDM4E 586/4885
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF IL4, IRAK4, IL5 MAPT 1262/4885ALDH1A1 3294/4885KDM4E 551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback